Refined mapping of the region of loss of heterozygosity on the long arm of chromosome 7 in human breast cancer defines the location of a second tumor suppressor gene at 7q22 in the region of the CUTL1 gene

被引:40
作者
Zeng, WR
Watson, P
Lin, J
Jothy, S
Lidereau, R
Park, M
Nepveu, A [1 ]
机构
[1] McGill Univ, Mol Oncol Grp, Dept Med, Montreal, PQ, Canada
[2] McGill Univ, Mol Oncol Grp, Dept Oncol, Montreal, PQ, Canada
[3] Univ Manitoba, Fac Med, Dept Pathol & Physiol, Winnipeg, MB R3T 2N2, Canada
[4] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada
[5] Ctr Rene Huguenin, Lab Oncogenet, F-92211 St Cloud, France
关键词
breast cancer; tumor suppressor gene; chromosome; 7q22; CUTL1; human Cut homeobox gene; loss of heterozygosity;
D O I
10.1038/sj.onc.1202519
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In breast cancer, loss of heterozygosity (LOH) has been described on the long arm of chromosome 7, at band q31, suggesting the presence of a tumor suppressor gene in this region, In this study, we have identified a second region of LOH on 7q, at band 7q22. Deletion of genetic material at 7q22 was found in all tumor types and grades and was associated with increased tumor size. The region of LOH at 7q22 in every case included one or more of three polymorphic markers that are located within the CUTL1 gene. LOH of 7q22 has also been documented in the case of human uterine leiomyomas (Zeng et al., 1997; Ishmad et al., 1997), Interestingly, in both leiomyomas and mammary tumors induced in transgenic mice expressing the Polyomavirus (PyV) large T (LT) antigen, immunocomplexes of CUTL1 and PyV LT antigen were detected (Webster et al., 1998), Altogether, genetic data in human breast cancer and biochemical analyses in breast tumors from transgenic mice suggest that CUTL1 is a candidate tumor suppressor gene.
引用
收藏
页码:2015 / 2021
页数:7
相关论文
共 49 条
[1]  
ANDRES V, 1992, DEVELOPMENT, V116, P321
[2]   Cytogenetic findings in thirty lung carcinoma patients [J].
Berker-Karaüzüm, S ;
Lüleci, G ;
Özbilim, G ;
Erdogan, A ;
Kuzucu, A ;
Demircan, A .
CANCER GENETICS AND CYTOGENETICS, 1998, 100 (02) :114-123
[3]   LOSS OF HETEROZYGOSITY ON CHROMOSOME-7Q AND AGGRESSIVE PRIMARY BREAST-CANCER [J].
BIECHE, I ;
CHAMPEME, MH ;
MATIFAS, F ;
HACENE, K ;
CALLAHAN, R ;
LIDEREAU, R .
LANCET, 1992, 339 (8786) :139-143
[4]  
Bieche I, 1997, CLIN CANCER RES, V3, P1009
[5]   GENETIC ALTERATIONS IN BREAST-CANCER [J].
BIECHE, I ;
LIDEREAU, R .
GENES CHROMOSOMES & CANCER, 1995, 14 (04) :227-251
[6]   GENETIC AND MOLECULAR HETEROGENEITY OF BREAST-CANCER CELLS [J].
CALLAHAN, R ;
CROPP, C ;
MERLO, GR ;
DIELLA, F ;
VENESIO, T ;
LIDEREAU, R ;
CAPPA, APM ;
LISICIA, DS .
CLINICA CHIMICA ACTA, 1993, 217 (01) :63-73
[7]   LOSS OF HETEROZYGOSITY ON 7Q31 OCCURS EARLY DURING BREAST TUMORIGENESIS [J].
CHAMPEME, MH ;
BIECHE, I ;
BEUZELIN, M ;
LIDEREAU, R .
GENES CHROMOSOMES & CANCER, 1995, 12 (04) :304-306
[8]   The mammalian Cut homeodomain protein functions as a cell-cycle-dependent transcriptional repressor which downmodulates p21WAF1/CIP1/SDI1 in S phase [J].
Coqueret, O ;
Bérubé, G ;
Nepveu, A .
EMBO JOURNAL, 1998, 17 (16) :4680-4694
[9]  
DAVE BJ, 1995, CANCER EPIDEM BIOMAR, V4, P743
[10]  
DENG G, 1994, CANCER RES, V54, P499